Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMolecular ImagingStress coping may protect against cognitive declineAdaptive coping was associated with better cognitive trajectories, independent of amyloid and tau PET brain pathology.Womens ImagingMammography-based radiomic models predict DCIS upstagingCT PreviewRoad to RSNA 2025: CT PreviewPatient SafetyLLMs improve patient comprehension of oncologic CT reportsSponsor ContentClinically Meaningful AI Detection of Interval Cancers